Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Strengthening the technical capacity at country-level to make informed policy decisions on new vaccine introduction: lessons learned by PAHO's ProVac Initiative.

Jauregui B, Sinha A, Clark AD, Bolanos BM, Resch S, Toscano CM, Matus CR, Andrus JK.

Vaccine. 2011 Jan 29;29(5):1099-106. doi: 10.1016/j.vaccine.2010.11.075. Epub 2010 Dec 7. Review.

PMID:
21144916
2.

ProVac Global Initiative: a vision shaped by ten years of supporting evidence-based policy decisions.

Jauregui B, Janusz CB, Clark AD, Sinha A, Garcia AG, Resch S, Toscano CM, Sanderson C, Andrus JK.

Vaccine. 2015 May 7;33 Suppl 1:A21-7. doi: 10.1016/j.vaccine.2014.12.080.

PMID:
25919164
3.

Descriptive analysis of immunization policy decision making in the Americas.

Burns JE, Mitrovich RC, Jauregui B, Matus CR, Andrus JK.

Rev Panam Salud Publica. 2009 Nov;26(5):398-404.

4.

Strengthening national decision-making on immunization by building capacity for economic evaluation: Implementing ProVac in Europe.

Blau J, Hoestlandt C, D Clark A, Baxter L, Felix Garcia AG, Mounaud B, Mosina L.

Vaccine. 2015 May 7;33 Suppl 1:A34-9. doi: 10.1016/j.vaccine.2014.12.073.

PMID:
25919171
5.

Establishing a regional network of academic centers to support decision making for new vaccine introduction in Latin America and the Caribbean: the ProVac experience.

Toscano CM, Jauregui B, Janusz CB, Sinha A, Clark AD, Sanderson C, Resch S, Ruiz Matus C, Andrus JK; ProVac Network of Centers of Excellence.

Vaccine. 2013 Jul 2;31 Suppl 3:C12-8. doi: 10.1016/j.vaccine.2013.05.033.

PMID:
23777685
6.

Evidence-based decision-making for vaccine introductions: Overview of the ProVac International Working Group's experience.

Jauregui B, Garcia AG, Bess Janusz C, Blau J, Munier A, Atherly D, Mvundura M, Hajjeh R, Lopman B, Clark AD, Baxter L, Hutubessy R, de Quadros C, Andrus JK.

Vaccine. 2015 May 7;33 Suppl 1:A28-33. doi: 10.1016/j.vaccine.2014.10.090.

7.

Systematic documentation of new vaccine introduction in selected countries of the Latin American Region.

de Oliveira LH, Toscano CM, Sanwogou NJ, Ruiz-Matus C, Tambini G, Roses-Periago M, Andrus JK.

Vaccine. 2013 Jul 2;31 Suppl 3:C114-22. doi: 10.1016/j.vaccine.2013.05.032. Review.

PMID:
23777684
8.

Human papillomavirus vaccine policy and delivery in Latin America and the Caribbean.

Andrus JK, Lewis MJ, Goldie SJ, García PJ, Winkler JL, Ruiz-Matus C, de Quadros CA.

Vaccine. 2008 Aug 19;26 Suppl 11:L80-7. doi: 10.1016/j.vaccine.2008.05.040. Review.

PMID:
18945405
9.

A model for enhancing evidence-based capacity to make informed policy decisions on the introduction of new vaccines in the Americas: PAHO's ProVac initiative.

Andrus JK, Toscano CM, Lewis M, Oliveira L, Ropero AM, Dávila M, Fitzsimmons JW.

Public Health Rep. 2007 Nov-Dec;122(6):811-6. No abstract available. Erratum in: Public Health Rep. 2008 Jan-Feb;123(1):table of contents. Oliveiria, Lucia [corrected to Oliveira, Lucia].

10.

Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program.

Tantivess S, Teerawattananon Y, Mills A.

Pharmacoeconomics. 2009;27(11):931-45. doi: 10.2165/11314710-000000000-00000. Review.

PMID:
19888793
11.

Challenges to building capacity for evidence-based new vaccine policy in developing countries.

Andrus JK, Jauregui B, De Oliveira LH, Ruiz Matus C.

Health Aff (Millwood). 2011 Jun;30(6):1104-12. doi: 10.1377/hlthaff.2011.0361.

12.

Strengthening health management: experience of district teams in The Gambia.

Conn CP, Jenkins P, Touray SO.

Health Policy Plan. 1996 Mar;11(1):64-71.

PMID:
10155879
13.

The Supporting Independent Immunization and Vaccine Advisory Committees (SIVAC) initiative: a country-driven, multi-partner program to support evidence-based decision making.

Senouci K, Blau J, Nyambat B, Coumba Faye P, Gautier L, Da Silva A, Favorov MO, Clemens JD, Stoeckel P, Gessner BD.

Vaccine. 2010 Apr 19;28 Suppl 1:A26-30. doi: 10.1016/j.vaccine.2010.02.028.

PMID:
20412992
14.

Supporting countries in establishing and strengthening NITAGs: lessons learned from 5 years of the SIVAC initiative.

Adjagba A, Senouci K, Biellik R, Batmunkh N, Faye PC, Durupt A, Gessner BD, da Silva A.

Vaccine. 2015 Jan 29;33(5):588-95. doi: 10.1016/j.vaccine.2014.12.026. Epub 2014 Dec 26. Review.

15.

The decision making process on new vaccines introduction in South Africa.

Ngcobo NJ, Cameron NA.

Vaccine. 2012 Sep 7;30 Suppl 3:C9-13. doi: 10.1016/j.vaccine.2012.04.027. Review.

PMID:
22939028
16.

A development framework for promoting evidence-based policy action: drawing on experiences in Sri Lanka.

Hornby P, Perera HS.

Int J Health Plann Manage. 2002 Apr-Jun;17(2):165-83.

PMID:
12126211
17.

Introduction of human papillomavirus vaccines into developing countries - international strategies for funding and procurement.

Andrus JK, Sherris J, Fitzsimmons JW, Kane MA, Aguado MT.

Vaccine. 2008 Aug 19;26 Suppl 10:K87-92. doi: 10.1016/j.vaccine.2008.05.003.

PMID:
18847561
19.

Strengthening capacity in developing countries for evidence-based public health: the data for decision-making project.

Pappaioanou M, Malison M, Wilkins K, Otto B, Goodman RA, Churchill RE, White M, Thacker SB.

Soc Sci Med. 2003 Nov;57(10):1925-37.

PMID:
14499516
20.

Women in water management: the need for local planning.

Bhatt MR.

Dev Pract. 1995 Aug;5(3):254-8.

PMID:
12346425

Supplemental Content

Support Center